Press Release: Algernon Pharmaceuticals Completes Manufacturing of Psychedelic Drug DMT Appoints UK Stroke Experts for Phase 2
Cannabis Law Report
DECEMBER 9, 2021
08, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. He was the London Stroke Clinical Director from 2010-2019 and the National Clinical Director for Stroke for NHS England from 2013-2019, where he oversaw dramatic improvements in the paradigm of NHS stroke treatment. Moreau CEO of Algernon Pharmaceuticals Inc. “We
Let's personalize your content